Monitoring Response to Neoadjuvant Chemotherapy of Primary Osteosarcoma Using Diffusion Kurtosis Magnetic Resonance Imaging: Initial Findings.
CONCLUSION: MD is a promising biomarker for monitoring tumor response to preoperative chemotherapy in patients with osteosarcoma.
PMID: 30993931 [PubMed - in process]
Source: Korean J Radiol - Category: Radiology Authors: Liu C, Xi Y, Li M, Jiao Q, Zhang H, Yang Q, Yao W Tags: Korean J Radiol Source Type: research
More News: Bone Cancers | Chemotherapy | MRI Scan | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Osteosarcoma | Radiology | Students | Universities & Medical Training | Women